Director/PDMR Shareholding

In brief · summary, not quotable

Kosmos Energy Limited announced that several Persons Discharging Managerial Responsibilities (PDMRs) have had changes in their shareholdings. Roy A. Franklin sold 976 shares for $2,781.60 and 43,466 shares for $118,662.18, while being granted 62,044 restricted share units valued at $170,000. Similarly, Sir John Douglas Kelso Grant sold 735 shares for $2,094.75 and 43,466 shares for $118,615.59, and received 62,044 restricted share units valued at $170,000. Deanna L. Goodwin, Maria Moraeus Hanssen, Adebayo O. Ogunlesi, J. Michael Stice, and Steven M. Sterin each received 62,044 restricted share units valued at $170,000, with Steven M. Sterin also selling 38,636 shares for $105,476.28. These transactions primarily involve the withholding of shares to cover tax liabilities and the granting of restricted share units.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your KOS notes

PDMR Shareholding

The following Persons Discharging Managerial Responsibilities ("PDMRs") have had changes in their shareholdings of Common Shares in the Company:

PDMR	Date of transaction	No. of shares vested	No. of shares granted	No. of shares sold or withheld
Roy A. Franklin	27 May 2026	0	0	976
Roy A. Franklin	28 May 2026	0	0	43,466
Roy A. Franklin	28 May 2026	0	62,044	0
Deanna L. Goodwin	28 May 2026	0	62,044	0
Sir John Douglas Kelso Grant	27 May 2026	0	0	735
Sir John Douglas Kelso Grant	27 May 2026	0	0	43,466
Sir John Douglas Kelso Grant	28 May 2026	0	62,044	0
Maria Moraeus Hanssen	28 May 2026	0	62,044	0
Adebayo O. Ogunlesi	28 May 2026	0	62,044	0
Steven M. Sterin	27 May 2026	0	0	38,636
Steven M. Sterin	28 May 2026	0	62,044	0
J. Michael Stice	28 May 2026	0	62,044	0
Josh R. Marion
Senior Vice President, General Counsel and Corporate Secretary
a)			Description of the financial instrument	Common Shares, par value $0.01 per share
b)			Nature of the transactions	976 shares withheld by the Issuer to satisfy the tax withholding requirement arising from the vesting of restricted share units granted to the reporting person under the Issuer's Long Term Incentive Plan (the "Plan").
Shares granted or vested
c)			Currency	USD
Price				0
Volume				0
Total				0
Shares sold or withheld
d)			Currency	USD
Price				2.85
Volume				976
Total				2,781.60
e)				Aggregated information
Price				2.85
Volume				976
Total				2,781.60
f)			Date of the transactions	27 May 2026
g)			Place of the transaction	NYSE
a)			Description of the financial instrument	Common Shares, par value $0.01 per share
Shares granted or vested
c)			Currency	USD
Price				0
Volume				0
Total				0
Shares sold or withheld
d)			Currency	USD
Price				2.73
Volume				43,466
Total				118,662.18
e)				Aggregated information
Price				2.73
Volume				43,466
Total				118,662.18
f)			Date of the transactions	28 May 2026
g)			Place of the transaction	NYSE
a)			Description of the financial instrument	Common Shares, par value $0.01 per share
b)			Nature of the transactions	62,044 restricted share units granted to the reporting person on May 28, 2026 under the Plan and are scheduled to vest 100% on the earlier of May 28, 2027 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c)			Currency	USD
Price				2.74
Volume				62,044
Total				170,000
Shares sold or withheld
d)			Currency	USD
Price				0
Volume				0
Total				0
e)				Aggregated information
Price				2.74
Volume				62,044
Total				170,000
f)			Date of the transactions	28 May 2026
g)			Place of the transaction	NYSE
			1.	Details of PDMR / person closely associated with them ("PCA")
a)			Name	Deanna L. Goodwin
b)			Position / status	Director
c)			Initial notification / amendment	Initial notification
a)			Description of the financial instrument	Common Shares, par value $0.01 per share
b)			Nature of the transactions	62,044 restricted share units granted to the reporting person on May 28, 2026 under the Plan and are scheduled to vest 100% on the earlier of May 28, 2027 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c)			Currency	USD
Price				2.74
Volume				62,044
Total				170,000
Shares sold or withheld
d)			Currency	USD
Price				0
Volume				0
Total				0
e)				Aggregated information
Price				2.74
Volume				62,044
Total				170,000
f)			Date of the transactions	28 May 2026
g)			Place of the transaction	NYSE
			1.	Details of PDMR / person closely associated with them ("PCA")
a)			Name	Sir John Douglas Kelso Grant
b)			Position / status	Director
c)			Initial notification / amendment	Initial notification
a)			Description of the financial instrument	Common Shares, par value $0.01 per share
b)			Nature of the transactions	735 shares withheld by the Issuer to satisfy the tax withholding requirement arising from the vesting of restricted share units granted to the reporting person under the Issuer's Long Term Incentive Plan (the "Plan").
Shares granted or vested
c)			Currency	USD
Price				0
Volume				0
Total				0
Shares sold or withheld
d)			Currency	USD
Price				2.85
Volume				735
Total				2,094.75
e)				Aggregated information
Price				2.85
Volume				735
Total				2,094.75
f)			Date of the transactions	27 May 2026
g)			Place of the transaction	NYSE
a)			Description of the financial instrument	Common Shares, par value $0.01 per share
Shares granted or vested
c)			Currency	USD
Price				0
Volume				0
Total				0
Shares sold or withheld
d)			Currency	USD
Price				2.73
Volume				43,466
Total				118,615.59
e)				Aggregated information
Price				2.73
Volume				43,466
Total				118,615.59
f)			Date of the transactions	27 May 2026
g)			Place of the transaction	NYSE
a)			Description of the financial instrument	Common Shares, par value $0.01 per share
b)			Nature of the transactions	62,044 restricted share units granted to the reporting person on May 28, 2026 under the Plan and are scheduled to vest 100% on the earlier of May 28, 2027 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c)			Currency	USD
Price				2.74
Volume				62,044
Total				170,000
Shares sold or withheld
d)			Currency	USD
Price				0
Volume				0
Total				0
e)				Aggregated information
Price				2.74
Volume				62,044
Total				170,000
f)			Date of the transactions	28 May 2026
g)			Place of the transaction	NYSE
			1.	Details of PDMR / person closely associated with them ("PCA")
a)			Name	Maria Moraeus Hanssen
b)			Position / status	Director
c)			Initial notification / amendment	Initial notification
a)			Description of the financial instrument	Common Shares, par value $0.01 per share
b)			Nature of the transactions	62,044 restricted share units granted to the reporting person on May 28, 2026 under the Plan and are scheduled to vest 100% on the earlier of May 28, 2027 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c)			Currency	USD
Price				2.74
Volume				62,044
Total				170,000
Shares sold or withheld
d)			Currency	USD
Price				0
Volume				0
Total				0
e)				Aggregated information
Price				2.74
Volume				62,044
Total				170,000
f)			Date of the transactions	28 May 2026
g)			Place of the transaction	NYSE
			1.	Details of PDMR / person closely associated with them ("PCA")
a)			Name	Adebayo O. Ogunlesi
b)			Position / status	Director
c)			Initial notification / amendment	Initial notification
a)			Description of the financial instrument	Common Shares, par value $0.01 per share
b)			Nature of the transactions	62,044 restricted share units granted to the reporting person on May 28, 2026 under the Plan and are scheduled to vest 100% on the earlier of May 28, 2027 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c)			Currency	USD
Price				2.74
Volume				62,044
Total				170,000
Shares sold or withheld
d)			Currency	USD
Price				0
Volume				0
Total				0
e)				Aggregated information
Price				2.74
Volume				62,044
Total				170,000
f)			Date of the transactions	28 May 2026
g)			Place of the transaction	NYSE
			1.	Details of PDMR / person closely associated with them ("PCA")
a)			Name	Steven M. Sterin
b)			Position / status	Director
c)			Initial notification / amendment	Initial notification
a)			Description of the financial instrument	Common Shares, par value $0.01 per share
Shares granted or vested
c)			Currency	USD
Price				0
Volume				0
Total				0
Shares sold or withheld
d)			Currency	USD
Price				2.73
Volume				38,636
Total				105,476.28
e)				Aggregated information
Price				2.73
Volume				38,636
Total				105,476.28
f)			Date of the transactions	27 May 2026
g)			Place of the transaction	NYSE
a)			Description of the financial instrument	Common Shares, par value $0.01 per share
b)			Nature of the transactions	62,044 restricted share units granted to the reporting person on May 28, 2026 under the Plan and are scheduled to vest 100% on the earlier of May 28, 2027 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c)			Currency	USD
Price				2.74
Volume				62,044
Total				170,000
Shares sold or withheld
d)			Currency	USD
Price				0
Volume				0
Total				0
e)				Aggregated information
Price				2.74
Volume				62,044
Total				170,000
f)			Date of the transactions	28 May 2026
g)			Place of the transaction	NYSE
			1.	Details of PDMR / person closely associated with them ("PCA")
a)			Name	J. Michael Stice
b)			Position / status	Director
c)			Initial notification / amendment	Initial notification
a)			Description of the financial instrument	Common Shares, par value $0.01 per share
b)			Nature of the transactions	62,044 restricted share units granted to the reporting person on May 28, 2026 under the Plan and are scheduled to vest 100% on the earlier of May 28, 2027 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c)			Currency	USD
Price				2.74
Volume				62,044
Total				170,000
Shares sold or withheld
d)			Currency	USD
Price				0
Volume				0
Total				0
e)				Aggregated information
Price				2.74
Volume				62,044
Total				170,000
f)			Date of the transactions	28 May 2026
g)			Place of the transaction	NYSE

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.